営業経費 変化する 日付
AstraZeneca USD 11.55B 674M 2026-09
Bayer EUR 9.92B 121M 2026-09
Essilor EUR 12.52B 568M 2026-06
Fresenius EUR 5.24B 19M 2026-09
Fresenius Medical Care EUR 4.55B 229.7M 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
GRIFOLS EUR 1.65B 101M 2026-09
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.97B 630M 2026-09
Novartis USD 9.88B 325M 2026-09
Philips EUR 4.23B 478M 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
Smith & Nephew USD 2.59B 71M 2026-06
Sonova Holding CHF 1.52B 59.9M 2025-12
UCB EUR 2.96B 196M 2025-12